astrazeneca glp 1 pipeline AstraZeneca's elecoglipron just posted some of the most closely watched Phase IIb data of the year and it landed at the right conference. Results from the VISTA and SOLSTICE trials, published simultaneously Latin America Glucagon-like Peptide-1 Agonists

JAMA network open , 7 (9), e2435247

At least thats what I found after subscribing for one month and diving in some of the content that was on his website and breaking down the references

Plasma-activated medium induces ferroptosis by depleting FSP1 in human lung cancer cells

The Link Between Inflammation and Chronic Diseases Inflammation is the bodys natural defense mechanism, but when it becomes chronic, it damages tissues and organs

Insulin and other diabetes medications: Growth hormone influences glucose metabolism, and elevations in GH activity can affect insulin sensitivity

Work together to create an action plan that allows you to track your healthcare goals year to year